Pages that link to "Q37259811"

The following pages link to Gastric bypass surgery reduces plasma ceramide subspecies and improves insulin sensitivity in severely obese patients (Q37259811):

Displaying 44 items.

• On ceramides, other sphingolipids and impaired glucose homeostasis (Q27021446) (← links)
• Ceramide as a mediator of non-alcoholic Fatty liver disease and associated atherosclerosis (Q28547365) (← links)
• Metabolic phenotype-microRNA data fusion analysis of the systemic consequences of Roux-en-Y gastric bypass surgery (Q30912007) (← links)
• Plasma sphingosine-1-phosphate is elevated in obesity (Q34988407) (← links)
• Roux-en-Y Gastric Bypass Surgery Induces Early Plasma Metabolomic and Lipidomic Alterations in Humans Associated with Diabetes Remission (Q35577707) (← links)
• Sphingolipids in cardiovascular diseases and metabolic disorders (Q35750931) (← links)
• Reduced cardiovascular risk after bariatric surgery is linked to plasma ceramides, apolipoprotein-B100, and ApoB100/A1 ratio (Q35916568) (← links)
• Serum sphingolipids: relationships to insulin sensitivity and changes with exercise in humans. (Q35958512) (← links)
• Role of ceramides in nonalcoholic fatty liver disease (Q36129432) (← links)
• Essential amino acid ingestion as an efficient nutritional strategy for the preservation of muscle mass following gastric bypass surgery (Q36359674) (← links)
• Ceramides contained in LDL are elevated in type 2 diabetes and promote inflammation and skeletal muscle insulin resistance (Q36560514) (← links)
• Plasma ceramides target skeletal muscle in type 2 diabetes (Q36560633) (← links)
• Plasma sphingolipids are biomarkers of metabolic syndrome in non-human primates maintained on a Western-style diet (Q37033895) (← links)
• Circulating ceramides are inversely associated with cardiorespiratory fitness in participants aged 54-96 years from the Baltimore Longitudinal Study of Aging (Q37235597) (← links)
• Longer-Term Physiological and Metabolic Effects of Gastric Bypass Surgery (Q37550281) (← links)
• Lipid metabolism in skeletal muscle: generation of adaptive and maladaptive intracellular signals for cellular function (Q37970188) (← links)
• Bariatric surgery: effects on the metabolic complications of obesity. (Q37979723) (← links)
• A role for sphingolipids in the pathophysiology of obesity-induced inflammation (Q37980387) (← links)
• Obesity and the liver: nonalcoholic fatty liver disease (Q38229961) (← links)
• Lipidomic profiling at the interface of metabolic surgery and cardiovascular disease. (Q38252517) (← links)
• Serum sphingolipids and inflammatory mediators in adolescents at risk for metabolic syndrome (Q38328903) (← links)
• Lipotoxic lethal and sublethal stress signaling in hepatocytes: relevance to NASH pathogenesis. (Q38799232) (← links)
• Lipid Biomarkers for Risk Assessment in Acute Coronary Syndromes (Q38825512) (← links)
• Serum lipidomics reveals early differential effects of gastric bypass compared with banding on phospholipids and sphingolipids independent of differences in weight loss. (Q38916357) (← links)
• Metabolomics-guided insights on bariatric surgery versus behavioral interventions for weight loss. (Q39021881) (← links)
• Lipidomic profiling before and after Roux-en-Y gastric bypass in obese patients with diabetes (Q39288685) (← links)
• Short Term Palmitate Supply Impairs Intestinal Insulin Signaling via Ceramide Production (Q42395469) (← links)
• The effect of short-term overfeeding on serum lipids in healthy humans (Q43982876) (← links)
• Evolution of lipid profiles after bariatric surgery (Q44245043) (← links)
• Sphingolipids in obesity and related complications (Q45046493) (← links)
• Bariatric Surgery-Induced Cardiac and Lipidomic Changes in Obesity-Related Heart Failure with Preserved Ejection Fraction (Q46240569) (← links)
• Untargeted metabolomics identifies a plasma sphingolipid-related signature associated with lifestyle intervention in prepubertal children with obesity. (Q46300676) (← links)
• A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction (Q48561722) (← links)
• Plasma Sphingolipids are Associated With Gait Parameters in the Mayo Clinic Study of Aging. (Q49609040) (← links)
• Time course metabolome of Roux-en-Y gastric bypass confirms correlation between leptin, body weight and the microbiome. (Q55156251) (← links)
• Changes in Serum Sphingomyelin After Roux-en-Y Gastric Bypass Surgery Are Related to Diabetes Status. (Q55290172) (← links)
• Lipid mediators of liver injury in nonalcoholic fatty liver disease (Q58077805) (← links)
• Early postoperative changes of sphingomyelins and ceramides after laparoscopic sleeve gastrectomy (Q59812054) (← links)
• Inflammatory markers and bariatric surgery: a meta-analysis (Q84139204) (← links)
• Dietary Fatty Acid Saturation Modulates Sphingosine-1-Phosphate-Mediated Vascular Function (Q90172205) (← links)
• Body weight-dependent and independent improvement in lipid metabolism after Roux-en-Y gastric bypass in ApoE*3Leiden.CETP mice (Q91595130) (← links)
• Effect of combined testing of ceramides with high-sensitive troponin T on the detection of acute coronary syndrome in patients with chest pain in China: a prospective observational study (Q92213726) (← links)
• Ceramide: a novel inducer for neural tube defects (Q92474229) (← links)
• Associations of Adiposity and Diet Quality with Serum Ceramides in Middle-Aged Adults with Cardiovascular Risk Factors (Q93182357) (← links)